CGEN

COMPUGEN LTDCIK 1119774 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for CGEN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for CGEN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Kredo Russo Sharon	SVP, Research & Discovery	4	$0	$0	2026-07-29
Mahler Michelle	Chief Medical Officer	4	$0	$0	2026-07-29
Perry Eran	Director	4	$0	$0	2026-07-29
Levine Zurit	SVP, Business Development	39	$0	$83.4K	2026-07-29
Ferre Pierre	Chief Operating Officer	2	$0	$0	2026-07-29
Halevy Gilead	Director	4	$0	$0	2026-07-29
Livnat Savitzky Kinneret	Director	4	$0	$0	2026-07-29
Ophir Eran	President and CEO, Director	11	$0	$42.9K	2026-07-29
Hukkelhoven Mathias	Director	4	$0	$0	2026-07-29
Cohen-Dayag Anat	Director	2	$0	$0	2026-07-29
Silberman David	Chief Financial Officer	4	$0	$0	2026-07-29
ZWEIFACH SANFORD S	Director	4	$0	$0	2026-07-29

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Mahler Michelle	Chief Medical Officer	A Award deriv	2026-07-29	2026-07-30	18,000	—	$0	18,000	SEC↗
ZWEIFACH SANFORD S	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Halevy Gilead	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Hukkelhoven Mathias	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Livnat Savitzky Kinneret	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Kredo Russo Sharon	SVP, Research & Discovery	A Award deriv	2026-07-29	2026-07-30	24,000	—	$0	24,000	SEC↗
Ferre Pierre	Chief Operating Officer	A Award deriv	2026-07-29	2026-07-30	70,000	—	$0	70,000	SEC↗
Perry Eran	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Cohen-Dayag Anat	Director	A Award deriv	2026-07-29	2026-07-30	100,000	—	$0	100,000	SEC↗
Ophir Eran	President and CEO	A Award deriv	2026-07-29	2026-07-30	200,000	—	$0	200,000	SEC↗
Silberman David	Chief Financial Officer	A Award deriv	2026-07-29	2026-07-30	26,000	—	$0	26,000	SEC↗
Levine Zurit	SVP, Business Development	A Award deriv	2026-07-29	2026-07-30	24,000	—	$0	24,000	SEC↗
Mahler Michelle	Chief Medical Officer	A Award	2026-07-29	2026-07-30	13,500	—	$0	36,625	SEC↗
ZWEIFACH SANFORD S	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	20,180	SEC↗
Halevy Gilead	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	18,907	SEC↗
Hukkelhoven Mathias	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	17,500	SEC↗
Livnat Savitzky Kinneret	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	20,850	SEC↗
Kredo Russo Sharon	SVP, Research & Discovery	A Award	2026-07-29	2026-07-30	18,000	—	$0	37,500	SEC↗
Perry Eran	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	17,500	SEC↗
Silberman David	Chief Financial Officer	A Award	2026-07-29	2026-07-30	19,500	—	$0	55,000	SEC↗
Levine Zurit	SVP, Business Development	A Award	2026-07-29	2026-07-30	18,000	—	$0	47,375	SEC↗
Levine Zurit	SVP, Business Development	A Award deriv	2026-07-29	2026-07-30	24,000	—	$0	24,000	SEC↗
Levine Zurit	SVP, Business Development	A Award	2026-07-29	2026-07-30	18,000	—	$0	47,375	SEC↗
Silberman David	Chief Financial Officer	A Award deriv	2026-07-29	2026-07-30	26,000	—	$0	26,000	SEC↗
Silberman David	Chief Financial Officer	A Award	2026-07-29	2026-07-30	19,500	—	$0	55,000	SEC↗
Ophir Eran	President and CEO, Director	A Award deriv	2026-07-29	2026-07-30	200,000	—	$0	200,000	SEC↗
Cohen-Dayag Anat	Director	A Award deriv	2026-07-29	2026-07-30	100,000	—	$0	100,000	SEC↗
Perry Eran	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Perry Eran	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	17,500	SEC↗
Ferre Pierre	Chief Operating Officer	A Award deriv	2026-07-29	2026-07-30	70,000	—	$0	70,000	SEC↗
Kredo Russo Sharon	SVP, Research & Discovery	A Award deriv	2026-07-29	2026-07-30	24,000	—	$0	24,000	SEC↗
Kredo Russo Sharon	SVP, Research & Discovery	A Award	2026-07-29	2026-07-30	18,000	—	$0	37,500	SEC↗
Livnat Savitzky Kinneret	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Livnat Savitzky Kinneret	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	20,850	SEC↗
Hukkelhoven Mathias	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Hukkelhoven Mathias	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	17,500	SEC↗
Halevy Gilead	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
Halevy Gilead	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	18,907	SEC↗
ZWEIFACH SANFORD S	Director	A Award deriv	2026-07-29	2026-07-30	10,000	—	$0	10,000	SEC↗
ZWEIFACH SANFORD S	Director	A Award	2026-07-29	2026-07-30	7,500	—	$0	20,180	SEC↗
Mahler Michelle	Chief Medical Officer	A Award deriv	2026-07-29	2026-07-30	18,000	—	$0	18,000	SEC↗
Mahler Michelle	Chief Medical Officer	A Award	2026-07-29	2026-07-30	13,500	—	$0	36,625	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-07-09	2026-07-13	1,875	—	$0	3,750	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-07-09	2026-07-13	1,875	$2.50	$4.7K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-07-09	2026-07-13	1,875	$0.83	$1.6K	31,250	SEC↗
Ophir Eran	President and CEO	M Exercise deriv	2026-04-24	2026-04-27	5,000	—	$0	14,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-24	2026-04-27	2,000	—	$0	52,000	SEC↗
Ophir Eran	President and CEO	S Sale	2026-04-24	2026-04-27	5,000	$3.20	$16.0K	11,375	SEC↗
Ophir Eran	President and CEO	M Exercise	2026-04-24	2026-04-27	5,000	$0.83	$4.2K	16,375	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-24	2026-04-27	2,000	$3.20	$6.4K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-24	2026-04-27	2,000	$1.15	$2.3K	31,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-14	2026-04-15	2,000	—	$0	54,000	SEC↗
Ophir Eran	President and CEO	M Exercise deriv	2026-04-14	2026-04-15	5,000	—	$0	19,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-14	2026-04-15	2,000	$1.15	$2.3K	31,375	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-14	2026-04-15	2,000	$2.80	$5.6K	29,375	SEC↗
Ophir Eran	President and CEO	M Exercise	2026-04-14	2026-04-15	5,000	$0.83	$4.2K	16,375	SEC↗
Ophir Eran	President and CEO	S Sale	2026-04-14	2026-04-15	5,000	$2.90	$14.5K	11,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-10	2026-04-13	2,000	—	$0	56,000	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-10	2026-04-13	1,125	—	$0	5,625	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-10	2026-04-15	2,000	—	$0	56,000	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-10	2026-04-15	1,125	—	$0	5,625	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-10	2026-04-13	2,000	$1.15	$2.3K	32,500	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-10	2026-04-13	1,125	$0.83	$934	30,500	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-10	2026-04-13	3,125	$2.56	$8.0K	29,375	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-10	2026-04-15	3,125	$2.56	$8.0K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-10	2026-04-15	2,000	$1.15	$2.3K	32,500	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-10	2026-04-15	1,125	$0.83	$934	30,500	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-08	2026-04-09	1,000	—	$0	58,000	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-08	2026-04-09	4,375	—	$0	6,750	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-08	2026-04-09	1,000	$1.15	$1.1K	34,750	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-08	2026-04-09	4,375	$0.83	$3.6K	33,750	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-08	2026-04-09	5,375	$2.42	$13.0K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-07	2026-04-09	2,500	—	$0	11,125	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-07	2026-04-09	2,500	$2.30	$5.8K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-07	2026-04-09	2,500	$0.83	$2.1K	31,875	SEC↗
Ophir Eran	President and CEO	M Exercise deriv	2026-04-01	2026-04-03	5,625	—	$0	24,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-01	2026-04-03	2,500	—	$0	13,625	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-04-01	2026-04-03	1,000	—	$0	59,000	SEC↗
Ophir Eran	President and CEO	S Sale	2026-04-01	2026-04-03	5,625	$2.21	$12.4K	11,375	SEC↗
Ophir Eran	President and CEO	M Exercise	2026-04-01	2026-04-03	5,625	$0.83	$4.7K	17,000	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-01	2026-04-03	1,000	$1.15	$1.1K	32,875	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-04-01	2026-04-03	3,500	$2.20	$7.7K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-04-01	2026-04-03	2,500	$0.83	$2.1K	31,875	SEC↗
Levine Zurit	SVP, Business Development	M Exercise deriv	2026-03-26	2026-03-30	11,875	—	$0	16,125	SEC↗
Levine Zurit	SVP, Business Development	S Sale	2026-03-26	2026-03-30	11,875	$2.04	$24.2K	29,375	SEC↗
Levine Zurit	SVP, Business Development	M Exercise	2026-03-26	2026-03-30	11,875	$0.83	$9.9K	41,250	SEC↗